Search

Your search keyword '"Furuta, Glenn"' showing total 1,576 results

Search Constraints

Start Over You searched for: Author "Furuta, Glenn" Remove constraint Author: "Furuta, Glenn"
1,576 results on '"Furuta, Glenn"'

Search Results

1. HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis

3. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial

4. Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with children

6. Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis

7. Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitis

8. Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis

9. Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis

11. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis

14. CSF1-dependent macrophage support matrisome and epithelial stress-induced keratin remodeling in Eosinophilic esophagitis

15. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time

16. A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME

17. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting

18. Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders.

19. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

20. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

21. Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis

25. Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations

27. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

28. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters

30. Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis

31. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial

32. Genome-wide admixture and association analysis identifies African ancestry–specific risk loci of eosinophilic esophagitis in African Americans

33. The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders

35. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study

36. Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes

37. Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis

38. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature

39. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference

41. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study

42. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

43. Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis

46. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis

47. Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field

48. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

49. Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review

50. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Catalog

Books, media, physical & digital resources